Maintenance of ischemic β cell viability through delivery of lipids and ATP by targeted liposomes

Nicole Atchison, Garrett Swindlehurst, Klearchos K. Papas, Michael Tsapatsis, Efrosini Kokkoli

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Islet transplantation is a promising treatment for type 1 diabetes, but despite the successes, existing challenges prevent widespread application. Ischemia, occurring during pancreas preservation and isolation, as well as after islet transplantation, decreases islet viability and function. We hypothesized that the liposomal delivery of adenosine triphosphate (ATP) could prevent the loss of cell viability during an ischemic insult. In this work we use a model β cell line, INS-1 to probe the liposome-cell interactions and examined the ability of liposomes functionalized with the fibronectin-mimetic peptide PR-b to facilitate the delivery of ATP to ischemic β cells. We demonstrate that PR-b increases the binding and internalization of liposomes to the β cells. Unexpectedly, when comparing the ability of PR-b liposomes with and without ATP to protect INS-1 cells from ischemia we found that both formulations increased cell survival. By probing the functional activity of ischemic cells treated with PR-b functionalized liposomes with and without ATP we find that both lipids and ATP play a role in maintaining cell metabolic activity after an ischemic insult and preventing cell necrosis. This approach may be beneficial for preventing ischemia related damage to islet cells, especially in the organ preservation stage.

Original languageEnglish (US)
Pages (from-to)548-559
Number of pages12
JournalBiomaterials science
Issue number4
StatePublished - Apr 2014


Dive into the research topics of 'Maintenance of ischemic β cell viability through delivery of lipids and ATP by targeted liposomes'. Together they form a unique fingerprint.

Cite this